- Intravenous Recombinant Human Prourokinase (rhPro-UK) for Acute Ischemic Stroke Within 4.5 to 24 Hours of OnsetNot yet recruitingNCT07942584Phase 3
Sponsor listed in the registry: Tasly Biopharmaceuticals Co., Ltd. · First submitted after Tasly Biopharmaceuticals Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUreRecruitingNCT07687186Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study of B2065 in Patients With Acute Ischemic StrokeRecruitingNCT07371624Phase 1/2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe DepressionNot yet recruitingNCT07485595Phase 2/3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMDNot yet recruitingNCT07269769Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary EfficacyRecruitingNCT07514065Phase 1
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Clinical Trial of P134 Cells in Recurrent GlioblastomaRecruitingNCT07318818Phase 1/2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress SyndromeRecruitingNCT06696261Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart FailureRecruitingNCT07265349Phase 1/2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted after Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease(NAFLD)RecruitingNCT07128797Phase 1
Sponsor listed in the registry: Tasly Biopharmaceuticals Co., Ltd. · First submitted after Tasly Biopharmaceuticals Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough TreatmentNot yet recruitingNCT06773117Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable AnginaRecruitingNCT03789552Phase 3
Sponsor listed in the registry: Tasly Pharmaceuticals, Inc. · First submitted before Tasly Pharmaceuticals, Inc. became part of China Resources Pharmaceutical Group Limited
- A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal CancerNot yet recruitingNCT06838546Phase 2
Sponsor listed in the registry: Tasly Biopharmaceuticals Co., Ltd. · First submitted before Tasly Biopharmaceuticals Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)Not yet recruitingNCT06753890Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid TumorsNot yet recruitingNCT06724263Phase 2
Sponsor listed in the registry: Tasly Biopharmaceuticals Co., Ltd. · First submitted before Tasly Biopharmaceuticals Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and PlaceboRecruitingNCT06000956Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common ColdRecruitingNCT06697886Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary GlandsRecruitingNCT06685978Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of Jia Shen Tablets in Chronic Heart FailureNot yet recruitingNCT06669169Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque PsoriasisRecruitingNCT06058546Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)RecruitingNCT05632861Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart FailureRecruitingNCT06348498Phase 1
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA MutationsRecruitingNCT05420779Phase 2
Sponsor listed in the registry: Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. · First submitted before Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid TumorsNot yet recruitingNCT05650385Phase 1
Sponsor listed in the registry: Tasly Biopharmaceuticals Co., Ltd. · First submitted before Tasly Biopharmaceuticals Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisCompletedNCT06068465Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)CompletedNCT06006689Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart FailureCompletedNCT04983043Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection FractionCompletedNCT04944706Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid TumorsCompletedNCT06238687Phase 1/2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty ArthritisCompletedNCT06068478Phase 3
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe DepressionCompletedNCT06259526Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.CompletedNCT05656274Phase 1
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation)CompletedNCT04229706Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT04492787Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in ChildrenCompletedNCT04457011Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)CompletedNCT04993729Phase 3
Sponsor listed in the registry: Tasly Pharmaceuticals, Inc. · First submitted before Tasly Pharmaceuticals, Inc. became part of China Resources Pharmaceutical Group Limited
- rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)CompletedNCT05700591Phase 3
Sponsor listed in the registry: Tasly Biopharmaceuticals Co., Ltd. · First submitted before Tasly Biopharmaceuticals Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19No longer availableNCT04646031
Sponsor listed in the registry: Tasly Pharmaceuticals, Inc. · First submitted before Tasly Pharmaceuticals, Inc. became part of China Resources Pharmaceutical Group Limited
- A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy SubjectsStatus unknownNCT05655221Phase 1
Sponsor listed in the registry: Tasly Biopharmaceuticals Co., Ltd. · First submitted before Tasly Biopharmaceuticals Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- A Trial of CRB4101 in Healthy SubjectsStatus unknownNCT05641181Phase 1
Sponsor listed in the registry: China Resources Biopharmaceutical Co., Ltd
- A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) SubjectsCompletedNCT04486963Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy SubjectsCompletedNCT04164290Phase 1
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Study of Jitongning Tablet to Treat SpondyloarthritisCompletedNCT03932019Phase 2
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- A Real World Study of the Treatment of Gastric Adenocarcinoma With HuachansuStatus unknownNCT05249244
Sponsor listed in the registry: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
- A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette SyndromeStatus unknownNCT05188274Not applicable
Sponsor listed in the registry: Tasly Pharmaceuticals, Inc. · First submitted before Tasly Pharmaceuticals, Inc. became part of China Resources Pharmaceutical Group Limited
- Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette SyndromeStatus unknownNCT05183594Not applicable
Sponsor listed in the registry: Tasly Pharmaceuticals, Inc. · First submitted before Tasly Pharmaceuticals, Inc. became part of China Resources Pharmaceutical Group Limited
- Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome (IBS)Status unknownNCT05113888Phase 2
Sponsor listed in the registry: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
- Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLCStatus unknownNCT05098990Phase 4
Sponsor listed in the registry: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
- A Study of Qishenyiqi Dripping Pills in Healthy ParticipantsCompletedNCT04471298Phase 1
Sponsor listed in the registry: Tasly Pharmaceutical Group Co., Ltd · First submitted before Tasly Pharmaceutical Group Co., Ltd became part of China Resources Pharmaceutical Group Limited
- Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS).Status unknownNCT04934059Phase 4
Sponsor listed in the registry: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.